Treating hypoxemic COVID-19 "ARDS" patients with almitrine: The earlier the better?
作者信息
Bendjelid Karim, Giraud Raphael, Von Düring Stephan
机构信息
Intensive Care Division, Geneva University Hospitals, Geneva, Switzerland; Geneva Haemodynamic Research Group, Geneva, Switzerland; Faculty of Medicine, University of Geneva, Geneva, Switzerland.
Intensive Care Division, Geneva University Hospitals, Geneva, Switzerland; Geneva Haemodynamic Research Group, Geneva, Switzerland; Faculty of Medicine, University of Geneva, Geneva, Switzerland.
出版信息
Anaesth Crit Care Pain Med. 2020 Aug;39(4):451-452. doi: 10.1016/j.accpm.2020.07.003. Epub 2020 Jul 9.
Abstract
摘要
相似文献
1
Treating hypoxemic COVID-19 "ARDS" patients with almitrine: The earlier the better?
Anaesth Crit Care Pain Med. 2020 Aug;39(4):451-452. doi: 10.1016/j.accpm.2020.07.003. Epub 2020 Jul 9.
2
Almitrine as a non-ventilatory strategy to improve intrapulmonary shunt in COVID-19 patients.
Anaesth Crit Care Pain Med. 2020 Aug;39(4):467-469. doi: 10.1016/j.accpm.2020.05.013. Epub 2020 Jun 4.
3
Effect of almitrine bismesylate and inhaled nitric oxide on oxygenation in COVID-19 acute respiratory distress syndrome.
Anaesth Crit Care Pain Med. 2020 Aug;39(4):471-472. doi: 10.1016/j.accpm.2020.05.014. Epub 2020 Jun 4.
4
Efficacy of Almitrine in the Treatment of Hypoxemia in Sars-Cov-2 Acute Respiratory Distress Syndrome.
Chest. 2020 Nov;158(5):2003-2006. doi: 10.1016/j.chest.2020.05.573. Epub 2020 Jun 6.
5
Could ruxolitinib be effective in patients with COVID-19 infection at risk of acute respiratory distress syndrome (ARDS)?
Ann Hematol. 2020 Jul;99(7):1675-1676. doi: 10.1007/s00277-020-04067-6. Epub 2020 May 14.
6
Dapsone, colchicine and olanzapine as treatment adjuncts to prevent COVID-19 associated adult respiratory distress syndrome (ARDS).
Med Hypotheses. 2020 Aug;141:109774. doi: 10.1016/j.mehy.2020.109774. Epub 2020 Apr 23.
7
P-selectin blockade in COVID-19-related ARDS.
Am J Physiol Lung Cell Mol Physiol. 2020 Jun 1;318(6):L1237-L1238. doi: 10.1152/ajplung.00202.2020.
8
Case 18-2020: A 73-Year-Old Man with Hypoxemic Respiratory Failure and Cardiac Dysfunction.
N Engl J Med. 2020 Jun 11;382(24):2354-2364. doi: 10.1056/NEJMcpc2002417.
9
Thrombolysis restores perfusion in COVID-19 hypoxia.
Br J Haematol. 2020 Sep;190(5):e270-e274. doi: 10.1111/bjh.17050. Epub 2020 Aug 17.
10
Treating hypoxemic patients with SARS-COV-2 pneumonia: Back to applied physiology.
Anaesth Crit Care Pain Med. 2020 Jun;39(3):389-390. doi: 10.1016/j.accpm.2020.04.003. Epub 2020 Apr 16.
引用本文的文献
1
Effect of intravenous almitrine on intubation or mortality in patients with COVID-19 acute hypoxemic respiratory failure: A multicentre, randomised, double-blind, placebo-controlled trial.
EClinicalMedicine. 2022 Oct;52:101663. doi: 10.1016/j.eclinm.2022.101663. Epub 2022 Sep 21.
2
Aromatic or Hetero-aromatic Directly Attached Tri and Tetrasubstituted Methanes: New Chemical Entities as Anti-Infectives.
Curr Med Chem. 2023;30(8):974-998. doi: 10.2174/0929867329666220823111812.
3
Pathophysiology of Acute Respiratory Distress Syndrome and COVID-19 Lung Injury.
Crit Care Clin. 2021 Oct;37(4):749-776. doi: 10.1016/j.ccc.2021.05.003. Epub 2021 May 28.
4
The Pathophysiology and Dangers of Silent Hypoxemia in COVID-19 Lung Injury.
Ann Am Thorac Soc. 2021 Jul;18(7):1098-1105. doi: 10.1513/AnnalsATS.202011-1376CME.
本文引用的文献
1
The vascular endothelium: the cornerstone of organ dysfunction in severe SARS-CoV-2 infection.
Crit Care. 2020 Jun 16;24(1):353. doi: 10.1186/s13054-020-03062-7.
2
Efficacy of Almitrine in the Treatment of Hypoxemia in Sars-Cov-2 Acute Respiratory Distress Syndrome.
Chest. 2020 Nov;158(5):2003-2006. doi: 10.1016/j.chest.2020.05.573. Epub 2020 Jun 6.
3
Almitrine as a non-ventilatory strategy to improve intrapulmonary shunt in COVID-19 patients.
Anaesth Crit Care Pain Med. 2020 Aug;39(4):467-469. doi: 10.1016/j.accpm.2020.05.013. Epub 2020 Jun 4.
4
Effect of almitrine bismesylate and inhaled nitric oxide on oxygenation in COVID-19 acute respiratory distress syndrome.
Anaesth Crit Care Pain Med. 2020 Aug;39(4):471-472. doi: 10.1016/j.accpm.2020.05.014. Epub 2020 Jun 4.
5
Management of COVID-19 Respiratory Distress.
JAMA. 2020 Jun 9;323(22):2329-2330. doi: 10.1001/jama.2020.6825.
6
Treating hypoxemic patients with SARS-COV-2 pneumonia: Back to applied physiology.
Anaesth Crit Care Pain Med. 2020 Jun;39(3):389-390. doi: 10.1016/j.accpm.2020.04.003. Epub 2020 Apr 16.
7
Basing Respiratory Management of COVID-19 on Physiological Principles.
Am J Respir Crit Care Med. 2020 Jun 1;201(11):1319-1320. doi: 10.1164/rccm.202004-1076ED.
8
COVID-19 Does Not Lead to a "Typical" Acute Respiratory Distress Syndrome.
Am J Respir Crit Care Med. 2020 May 15;201(10):1299-1300. doi: 10.1164/rccm.202003-0817LE.
9
Hypoxic pulmonary vasoconstriction: physiology and anesthetic implications.
Anesthesiology. 2015 Apr;122(4):932-46. doi: 10.1097/ALN.0000000000000569.
10
Physiology in medicine: importance of hypoxic pulmonary vasoconstriction in maintaining arterial oxygenation during acute respiratory failure.
Crit Care. 2001;5(2):67-71. doi: 10.1186/cc989. Epub 2001 Mar 6.
Zotero 插件